Correlation Between Corvus Pharmaceuticals and Pluri
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Pluri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Pluri into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Pluri Inc, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Pluri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Pluri. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Pluri.
Diversification Opportunities for Corvus Pharmaceuticals and Pluri
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Corvus and Pluri is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Pluri Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluri Inc and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Pluri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluri Inc has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Pluri go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Pluri
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 1.16 times more return on investment than Pluri. However, Corvus Pharmaceuticals is 1.16 times more volatile than Pluri Inc. It trades about 0.25 of its potential returns per unit of risk. Pluri Inc is currently generating about -0.04 per unit of risk. If you would invest 202.00 in Corvus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 692.00 from holding Corvus Pharmaceuticals or generate 342.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.21% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Pluri Inc
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| Pluri Inc |
Corvus Pharmaceuticals and Pluri Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Pluri
The main advantage of trading using opposite Corvus Pharmaceuticals and Pluri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Pluri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluri will offset losses from the drop in Pluri's long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |